Our pipeline consists of proprietary applications of our pediculocidal and insecticidal platform effective for controlling all life-cycle stages of human lice and companion animal fleas.
ECTOGuard is advancing a proprietary suspension concentrate pediculocide formulation for controlling human lice towards EPA registration. This product is intended for direct application on non-washable textile surfaces such as furniture, bedding and carpets. This product is effective against pyrethrin resistant lice and eliminates all lifecycle stages including adults, larvae and ova.
ECTOGuard is also advancing a proprietary suspension concentrate insecticidal formulation for control of companion animal fleas. This product is intended for direct application in and around animal premises including bedding areas, kennels, crates. It is also suitable for use in non-residential facilities including veterinary clinics, animal daycare, boarding facilities and grooming establishments
ECTOGuard has established a partnering and development collaboration with a veterinary pharmaceutical company for our proprietary solution formulation of spinosad. This product for spot-on application to companion animals is being developed to control flea infestations. In addition to providing opportunities to validate our technology, these agreements provide non-dilutive capital through upfront, milestone and royalty payments.
ECTOGuard will continue to evaluate partnership/licensing opportunities for its research programs on a case-by-case basis with pharmaceutical and consumer product companies possessing complementary capabilities.
Copyright © 2024 EctoGuard, LLC - All Rights Reserved.